Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
17 angezeigte Treffer · Seite 2, keine Gesamtzahl für „comparison“
Suchtreffer
Begriffe & Kennungen
Phesgo · 4.5 · By comparison of simulated serum trastuzumab concentrations after trastuzumab monotherapy (4 mg/kg loading/2 m
Eintrag öffnenPhesgo · 4.5 · Comparison of trastuzumab PK data from Study M77004 in which women with HER2-positive metastatic breast cancer
Eintrag öffnenPrezista · 4.5 · Atazanavir: comparison of atazanavir/ritonavir 300/100 mg once daily vs. atazanavir 300 mg once daily in combi
Eintrag öffnenPrezista · 4.5 · Saquinavir: comparison of saquinavir/ritonavir 1,000/100 mg twice daily vs. saquinavir/darunavir/ritonavir 1,0
Eintrag öffnenRemsima · 4.8 · Because immunogenicity analyses are assay-specific, comparison of the incidence of antibodies to infliximab re
Eintrag öffnenReyataz · 4.5 · **Based on historical comparison.
Eintrag öffnenSozialer Vergleich
Eintrag öffnenTeysuno · 4.8 · Comparison of 218 patients with mild renal impairment at baseline (CrCl 51 to 80 ml/min) to 297 patients with
Eintrag öffnenTeysuno · 4.8 · Comparison of 218 patients with mild renal impairment at baseline (CrCl 51 to 80 ml/min) to 297 patients with
Eintrag öffnenTeysuno · 4.8 · Comparison of safety between 71 patients ≥70 years old (elderly) and 450 patients <70 years old treated with T
Eintrag öffnenTeysuno · 4.8 · Comparison of safety between 71 patients ≥70 years old (elderly) and 450 patients <70 years old treated with T
Eintrag öffnenThalidomide BMS (previously Thalidomide Celgene) · 4.8 · 13 Table 4: Comparison of haematological disorders for the melphalan, prednisone (MP) and melphalan, prednison
Eintrag öffnenTranskultureller Vergleich
Eintrag öffnenTrazimera · 4.5 · By comparison of simulated serum trastuzumab concentrations after trastuzumab monotherapy (4 mg/kg loading/2 m
Eintrag öffnenTrazimera · 4.5 · Comparison of PK results from two Phase II studies (BO15935 and M77004) and one Phase III study (H0648g) in wh
Eintrag öffnenZaltrap · 4.5 · Population pharmacokinetics analysis and inter study comparisons did not reveal any pharmacokinetic drug-drug
Eintrag öffnenZaltrap · 4.8 · 9 having ≥ 2 % greater incidence (all grades) in the aflibercept treatment group in comparison to the placebo
Eintrag öffnen